1134822-07-3 Usage
Uses
Used in Pharmaceutical Industry:
Kalydeco hydrate is used as a therapeutic agent for the treatment of cystic fibrosis in patients with specific gene mutations. It is utilized for its ability to target and improve the function of the defective protein, leading to enhanced lung function and a reduced frequency of respiratory infections.
Used in Healthcare:
Kalydeco hydrate is used as a medication to manage the symptoms and progression of cystic fibrosis, providing relief and improving the quality of life for affected individuals. It is crucial for patients taking this medication to be closely monitored by healthcare providers to ensure its effectiveness and to manage any potential side effects, such as dizziness, headache, and nausea.
Check Digit Verification of cas no
The CAS Registry Mumber 1134822-07-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,3,4,8,2 and 2 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1134822-07:
(9*1)+(8*1)+(7*3)+(6*4)+(5*8)+(4*2)+(3*2)+(2*0)+(1*7)=123
123 % 10 = 3
So 1134822-07-3 is a valid CAS Registry Number.
1134822-07-3Relevant academic research and scientific papers
SOLID FORMS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXAMIDE
-
Page/Page column 49, (2009/04/25)
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide are described herein, including crystalline forms thereof.
